Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

Irene M Shui; Sara Lindstroem; Adam S Kibel; Sonja I Berndt; Daniele Campa; Travis Gerke; Kathryn L Penney; Demetrius Albanes; Christine Berg; H Bas Bueno-de-Mesquita; Stephen Chanock; E David Crawford; W Ryan Diver; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Brian Henderson; Robert Hoover; Mattias Johansson; Loic Le Marchand; Jing Ma; Carmen Navarro; Kim Overvad; Fredrick R Schumacher; Gianluca Severi; Afshan Siddiq; Meir Stampfer; Victoria L Stevens; Ruth C Travis; Dimitrios Trichopoulos; Paolo Vineis; Lorelei A Mucci; Meredith Yeager; Edward Giovannucci; Peter Kraft

Journal article

Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium

Irene M Shui, Sara Lindstroem, Adam S Kibel, Sonja I Berndt, Daniele Campa, Travis Gerke, Kathryn L Penney, Demetrius Albanes, Christine Berg, H Bas Bueno-de-Mesquita, Stephen Chanock, E David Crawford, W Ryan Diver, Susan M Gapstur, J Michael Gaziano, Graham G Giles, Brian Henderson, Robert Hoover, Mattias Johansson, Loic Le Marchand Show all

European Urology | ELSEVIER | Published : 2014

DOI: 10.1016/j.eururo.2013.12.058

University of Melbourne Researchers

Graham Giles Author Melbourne School of Population and Global Health

Gianluca Severi Author Melbourne School of Population and Global Health

Grants

Awarded by NIH NCI

Awarded by NCI

Awarded by regional government of Murcia

Awarded by ISCIII RETIC (Spain)

Awarded by Cancer Research UK

Funding Acknowledgements

This work was supported by the NIH NCI (cooperative agreement U19 CA148537-01). The maintenance of the Cancer Prevention Study II is supported by the American Cancer Society, and genotyping of the CPS-II samples was supported by a grant from the NCI (5U01CA098710). The Danish study Diet, Cancer and Health was funded by the Danish Cancer Society. EPIC-Greece was supported through the Hellenic Health Foundation. EPIC-Spain was supported by Health Research Fund; the regional governments of Andalucia, Asturias, Basque Country, Murcia (No. 6236), and Navarra; and ISCIII RETIC (RD06/0020; Spain). PLCO was supported by the intramural program of the Division of Cancer Epidemiology and Genetics, NCI. The Melbourne Collaborative Cohort Study recruitment was funded and its follow-up supported by Cancer Council Victoria.